HCC Experts Round Table examines the impact of the IMbrave150 trial on evolving standards of care for advanced hepatocellular carcinoma (Asia-Pacific)
In July 2020, the HCC Experts Round Table brought together international experts in hepatocellular carcinoma. This interdisciplinary group (oncology, surgical oncology, hepatology, patient advocacy, and health economics) explored evolving standards of care for advanced first-line HCC, particularly in light of recently presented IMbrave150 phase III clinical trial data.
The views expressed in this video are that of the expert and do not necessarily represent the views of the expert’s academic institution, employer, organisation, or other group or individual. This programme is supported by an Independent Educational Grant from Roche.